Table 2.
Patients with diabetic ketoacidosis in COVID-19 surges 1 and 2 vs same periods in 2019
| A, Patients with DKA in COVID-19 surges 1 and 2 vs same periods in 2019, No. (% of T1D patients) | ||||||
|---|---|---|---|---|---|---|
| March-May (corresponding to COVID-19 surge 1) | August-October (corresponding to COVID-19 surge 2) | <?Char=Decimal?> | ||||
| 2019 | 2020 | P | 2019 | 2020 | P | |
| Total T1D patients with encounters a in reporting period | 13 852 | 11 178 | 13 703 | 13 557 | ||
| Total No. of patients with DKA | 751 (5.42) | 793 (7.09) | < .001 | 776 (5.66) | 897 (6.61) | .001 |
| No. of established patients with DKA | 643 (4.71) | 676 (6.15) | < .001 | 661 (4.90) | 738 (5.55) | .02 |
| B, Distribution of patient characteristics with DKA in COVID-19 surges 1 and 2 vs same periods in 2019, No. (% of T1D patients) | ||||||
| 2019 | 2020 | P | 2019 | 2020 | P | |
| (N = 751) | (N = 793) | (N = 776) | (N = 897) | |||
| DKA by age, y | ||||||
| 0-19 | 253 (33.69) | 245 (30.90) | .26 | 294 (37.89) | 311 (34.67) | .1 |
| 20-60 | 273 (36.35) | 282 (35.56) | .78 | 274 (35.31) | 305 (34.00) | .5 |
| ≥ 60 | 225 (29.96) | 266 (33.54) | .14 | 208 (26.80) | 281 (31.33) | .07 |
| DKA with COVID-19 | – | 23 (2.96) | – | 6 (0.69) | ||
| DKA by sex | ||||||
| Male | 362 (48.20) | 406 (51.20) | .26 | 397 (51.16) | 480 (53.51) | .5 |
| DKA by race/ethnicity | ||||||
| NHW | 521 (69.37) | 557 (70.24) | .75 | 506 (65.21) | 601 (67.00) | .7 |
| NHB | 120 (15.98) | 147 (18.54) | .2 | 128 (16.49) | 170 (18.95) | .2 |
| Hispanic | 53 (7.06) | 49 (6.18) | .5 | 67 (8.63) | 66 (7.36) | .3 |
| Asian | 21 (2.80) | 22 (2.77) | ≥ .999 | 15 (1.93) | 14 (1.56) | .6 |
| Others/Not reported | 36 (4.80) | 18 (2.26) | .01 | 42 (5.41) | 46 (5.12) | .98 |
| DKA by HbA 1c b , % | ||||||
| < 7 | 120 (15.98) | 117 (14.75) | .5 | 98 (12.63) | 147 (16.39) | .04 |
| 07-Sep | 93 (12.38) | 81 (10.21) | .2 | 104 (13.40) | 117 (13.04) | .8 |
| > 9 | 250 (33.29) | 224 (28.25) | .03 | 263 (33.89) | 281 (31.33) | .2 |
| Patients with DKA using CGM | 105 (13.98) | 90 (11.35) | .1 | 123 (15.85) | 139 (15.50) | .8 |
| Patients with DKA using insulin pump | 77 (10.25) | 51 (6.43) | .008 | 87 (11.21) | 73 (8.14) | .03 |
Abbreviations: CGM, continuous glucose monitor; DKA, diabetic ketoacidosis; HbA1c, glycated hemoglobin A1c; NHB, non-Hispanic Black; NHW, non-Hispanic White; T1D, type 1 diabetes.
a In-person or telemedicine.
b Where data available.